Canada Canada working on solution for vaccine patent waivers, not ‘blocking’: Trudeau
COVID protocol-related absences: 04/27/21
Each day, the NHL will publicly release the list of players that are unavailable to their respective teams due to being in COVID-19 Protocol. Here is today’s list: Anaheim – Adam Henrique Calgary – Josh Leivo Montreal – TBA New Jersey – P.K.Anaheim – Adam Henrique
Canada is working on a "consensus-based solution" around the question of waiving intellectual property rights on, Prime Minister said Friday.
The discussions involve "various different partners who have various different opinions," Trudeau said, and that his government is "working with others around the world to come up with a solution."
"We're engaged wholeheartedly in these discussions on various proposals," he said at a press conference.
Canada is holding back its 1-shot J&J COVID-19 vaccine. Here’s what you need to know
Health Canada on Friday said that they were holding back 300,000 doses of the one-shot J&J vaccine — mere days before they were meant to be deployed.On Friday, Health Canada announced it is holding back the J&J vaccine, a one-shot dose that experts and health officials touted as crucial in stemming the spread of the virus amid a devastating third wave of the pandemic, after it was revealed that parts of the batch were made in the same Baltimore plant where millions of other doses meant for the U.S. market had spoiled.
"I can assure you that Canada is not interfering or blocking. Canada is very much working to find a solution that works for everyone."
Trudeau said he believes the change in the U.S. position will "help us find a solution," though he offered little clarity on how that "consensus-based solution" would be reached.
Technically, any single country could block a decision at the WTO to agree to a waiver.
"I’d like to emphasize that this work, that the WTO’s job, is to find a consensus and that’s what happening right now," he said.
"The U.S. has its position, the Europeans have their position, developing countries have other positions on the matter. ... We’re working together to solve this problem. That’s how we’ll ensure that people around the world will have access to vaccines as quickly as possible to get through this pandemic."
U.S. backs waiver on vaccine patents. What it means and what Canada thinks
The U.S. and EU support is a 'signal that IP rights can legitimately be limited' during a health crisis like COVID-19, one expert said.The U.S. announced Wednesday it now supports a proposal to waive intellectual property (IP) protection to help boost the global COVID-19 vaccine supply. The European Union is also willing to discuss the waiver.
His comments follow the news this week that the United States will support a proposal to waive IP protection to help boost the global COVID-19 vaccine supply. The European Union has also said it is willing to discuss the proposal.
More than 100 other countries, led by India and South Africa, have for months been asking richer countries — fellow World Trade Organization (WTO) members — to agree to a temporary lifting of COVID-19-related IP rights.
The goal is to allow nations to produce more vaccines using the formulas and manufacturing techniques that have already been established by pharmaceutical companies leading the global vaccination effort. The companies argue that those leading suppliers should share their knowledge so that more countries can start producing both domestically for their own populations and for the lowest-income nations.
Why BionTech Founder Özlem doorCI against the easing of patent protection for vaccines has been proclaimed
since US President Joe Biden, his government supported a patent release of the Corona vaccines, has started the debate internationally to travel. The French President Emmanuel Macron and the EU also signals its openness - but the Federal Government is rejects patent release for vaccines from . Özlem DoorCi, a mit greenery of the German vaccine pioneer Biontech, has also pronounced patent release in an interview with the US news channel CNN.
Canada has so far been unwilling to offer firm support for the proposal.
Canada's International Trade Minister, Mary Ng, said Friday that Canada was "ready to discuss" an IP waiver for COVID-19 vaccines, but stressed the importance of protecting IP and the integral role industry played in developing the medicines.
She said Canada looks forward to a "speedy resolution" for "all barriers to vaccines, whether it be production or supply chains or export restrictions."
The co-chair of Canada’s federal COVID-19 vaccine task force described the transfer of technology on Tuesday as “time-consuming.”
“It certainly wouldn’t have gotten us vaccines this year. I don’t think it would’ve gotten us vaccines next year. It is something that’s being looked at, as what I would call a medium-term or long-term solution,” he said during a committee hearing.
Experts largely agree the path to approving the waiver could be lengthy and complex. Even once approved, it's not easily implemented.
The West Block — Episode 33, Season 10
Watch the full episode of The West Block on Sunday, May 9, 2021Episode 33, Season 10
Drugmakers have voiced concerns about the latter, arguing the plan is ineffective and that too few countries have the capacity to make more vaccines, even if they knew the formulas.
Some, like Moderna, insist it won't help boost supply in the short term. Countries in opposition, like Great Britain and Switzerland, argue it would undermine incentives for manufacturers to be as speedy and efficient on life-saving drugs during a future health crisis.
But the U.S. support is largely being seen as a significant step forward in the effort.
The WTO chief said Friday that the U.S. proposal to discuss waiving patent protections on vaccines will intensify talks on the issue and "give impetus" to negotiations.
However, Ngozi Okonjo-Iweala told a virtual conference that the trade body aimed to find a "pragmatic solution that assures access to developing countries to deal with vaccine inequity, whilst at the same time making sure we don't disincentivize research and innovation.''
Experts in Canada are keen to see the country jump on board.
"I think it signals something,” Myra Tawfik, a professor at the University of Windsor and an expert in intellectual property law, told Global News in a previous interview.
“Places like the U.S. and EU — strong patent holders — will recognize that there are times when the intellectual property rights need to be superseded by larger global public interest issues."
— with files from Reuters
COVID protocol-related absences: 05/13/21 .
Each day, the NHL will publicly release the list of players that are unavailable to their respective teams due to being in COVID-19 Protocol. Here is today’s list: © Isaiah J. Downing-USA TODAY Sports Colorado – Devan DubnykSt. Louis – Jake WalmanWashington – Evgeny KuznetsovAs a reminder, inclusion on this list does not mean that a player has tested positive for Coronavirus or even that they have been confirmed as a close contact to another positive person.